SO, WHAT ARE
CANNABINOIDS?

CBD for Pets:

Cannabinoids come from the hemp plant. CBD and THC are the most well-known cannabinoids, but the hemp plant contains at least 118 of these individual molecules, each with the potential to help in different ways.

At CHOU2 PHARMA/CHOU2 PET WELLNESS, we’ve taken the science of helping dogs down to the molecular level, isolating only what we need to target a pet’s needs. 

While many other cannabinoid products do contain small amounts of THC, our purification techniques remove all of it, with no psychotropic effects on pets. CHOU2 PHARMA/CHOU2 PET WELLNESS stands for purity and precision.

Our formulas offer precise levels of just the right molecules, providing products you and your pup can rely on.

Learn More:

Mark Cushing leads CHOU2 PHARMA’s advocacy and legal efforts—working closely with his external network and Dr. Jeff Pollard—to improve the understanding, education, and policy regarding cannabinoid pet health care. His focus is supporting veterinarians’ ability to discuss and recommend cannabinoid-based products within their practices.

Mr. Cushing provides high-level strategic advice, state and federal lobbying, regulatory and policy services, and consulting to animal health and veterinary clients throughout North America. Since 2004, he has specialized in animal health, animal welfare, veterinary, and veterinary educational issues, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mr. Cushing has guided successful AVMA (American Veterinary Medical Association) accreditations for a growing list of veterinary colleges, including new accreditations.

A frequent speaker at veterinary medicine and other animal policy conferences, he’s an adjunct professor of law at the Duncan School of Law in Knoxville, Lewis & Clark Law School in Portland, and the University of Oregon School of Law. He’s also an honors graduate with distinction from Stanford University and the Willamette University College of Law.

As the founder and managing partner of the Animal Policy Group, LLC (APG), Mr. Cushing offers representation for a wide range of veterinary and pet health interests. Most recently, Mr. Cushing authored Pet Nation, a Penguin Random House title that explores the forces behind pets becoming treasured members of the family.

Mark Cushing leads CHOU2 PHARMA’s advocacy and legal efforts—working closely with his external network and Dr. Jeff Pollard—to improve the understanding, education and policy regarding cannabinoid pet health care. His focus is supporting veterinarians’ ability to discuss and recommend cannabinoid-based products within their practices.

Mr. Cushing provides high-level strategic advice, state and federal lobbying, regulatory and policy services and consulting to animal health and veterinary clients throughout North America. Since 2004, he has specialized in animal health, animal welfare, veterinary and veterinary educational issues, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mr. Cushing has guided successful AVMA (American Veterinary Medical Association) accreditations for a growing list of veterinary colleges, including new accreditations.

A frequent speaker at veterinary medicine and other animal policy conferences, he’s an adjunct professor of law at the Duncan School of Law in Knoxville, Lewis & Clark Law School in Portland and the University of Oregon School of Law. He’s also an honors graduate with distinction from Stanford University and the Willamette University College of Law.

As the founder and managing partner of the Animal Policy Group, LLC (APG), Mr. Cushing offers representation for a wide range of veterinary and pet health interests. Most recently, Mr. Cushing authored Pet Nation, a Penguin Random House title that explores the forces behind pets becoming treasured members of the family.